Compare Cronos Group Inc (CRON) vs Freshworks Inc (FRSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Freshworks Inc — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while Freshworks Inc trades at $13.79 (market cap $3.56B). The key difference: Freshworks Inc is far larger — about 3× Cronos Group Inc's market cap, and Freshworks Inc is trading nearer its 52-week high, Cronos Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Freshworks Inc for 39 Days on average.
| CRON | FRSH | |
|---|---|---|
Market Cap | $1.18B | $3.56B |
Volume | 968,037 | 9,066,454 |
Sector | Health | Technology |
52-Week High | $3.55 | $13.92 |
52-Week Low | $2.30 | $6.88 |
Typical Hold Time | 22 Days | 39 Days |
Enterprise Value | $387.62M | $2.93B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.24, down 1.37% on the day, with a bearish technical signal and neutral oscillators. The company reported a net loss of $9.45M in 2025 despite revenue growth to $146.59M, but recent quarters show earnings beats. Analyst sentiment is mixed with 20% buy, 60% hold, and 20% sell ratings. Recent news highlights investor day events and international expansion efforts.
The outlook is cautious; profitability improvements and cash flow generation are key catalysts, but high valuation multiples and negative net cash flow pose risks. Regulatory developments in cannabis markets and execution on growth targets will be critical for stock performance.
Freshworks (FRSH) trades at $13.60, down 1.16% today, with strong technical momentum showing bullish moving averages despite overbought RSI readings. The company achieved its first GAAP profitability in Q2 2026 with revenue growth of 16% year-over-year, while maintaining impressive gross margins of 84.96%. Recent developments include FedRAMP certification progress and leadership in Gartner's ITSM Magic Quadrant.
The outlook remains positive with analyst consensus at $14.60 target (7.4% upside) and balanced buy/hold ratings. Key opportunities include AI monetization and enterprise expansion, while risks involve competitive SaaS pressures and execution on growth targets. The stock presents a compelling value proposition with improving profitability metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Freshworks Inc
Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CX and ITSM categories, and have also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and better serve their customers and employees.
Read more on FRSH →
